SCHEMBL6516740

SCHEMBL6516740

Cc1c(N)[nH]c(=O)c(-c2ccc(Cl)cc2)c1-c1ccncc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GCGR P47871 5/20 0.45
CSF1R P07333 1/20 0.43
PDE3B Q13370 1/20 0.41
PDE3A Q14432 1/20 0.41
AURKB Q96GD4 1/20 0.41
INCENP Q9NQS7 1/20 0.41
IKBKB O14920 1/20 0.41
MAP3K14 Q99558 1/20 0.41
MAPK14 Q16539 4/20 0.40
CDK5 Q00535 2/20 0.40
CDK5R1 Q15078 2/20 0.40
SLC2A1 P11166 1/20 0.39
PSD A5PKW4 1/20 0.38
CCNB2 O95067 1/20 0.38
CDK1 P06493 1/20 0.38
CCNB1 P14635 1/20 0.38
GSK3A P49840 1/20 0.38
GSK3B P49841 1/20 0.38
CCNB3 Q8WWL7 1/20 0.38
MAPK13 O15264 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3555150 0.76 GCGR (0.58) GCGRMAPK14PSDGSK3BMAPK13
SCHEMBL5215641 0.68 MAPK14 (0.71) GCGRMAPK14GSK3BMAPK13MAPK12
SCHEMBL17457312 0.68 CSF1R (0.70) CSF1RMAPK14CDK5CDK5R1GSK3A
SCHEMBL5255543 0.67 MAPK11 (0.52) GCGRIKBKBMAP3K14MAPK14MAPK13
SCHEMBL5214789 0.67 GCGR (0.46) GCGRCSF1RMAPK14PSDMAPK13
SCHEMBL27224358 0.66 GSK3B (0.50) GCGRCSF1RMAPK14PSDGSK3B
SCHEMBL14680953 0.66 MAPT (0.58)
SCHEMBL6936901 0.66 GCGR (0.67) GCGRMAPK14
SCHEMBL3554322 0.66 CNR1 (0.57) GCGRMAPK14PSDMAPK13MAPK12
SCHEMBL196861 0.66 GCGR (0.67) GCGRMAPK14MAPK13MAPK12MAPK11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1506186-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS AND METHODS OF USE Amgen Inc. (US) 2005-02-16 EP disclosed
WO-2003099808-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS AND METHODS OF USE AMGEN INC. (US) 2003-12-04 WO disclosed